{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"53.12","value":"97.00"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"description":"To determine the maximum concentration of dihydroartemisinin (DHA) (Cmax) following five consecutive days of self-administration of 200mg Artesunate vaginal inserts (pessaries) among healthy women.\n\nMean DHA Cmax (ng/ml) value will be submitted.","dispersionType":"Standard Deviation","groups":[{"description":"Artesunate vaginal inserts/pessaries are used as a treatment for cervical precancerous lesions.\n\nArtesunate pessary: Subjects will use the study pessaries, placed in the vagina every day for 5 consecutive days.","id":"OG000","title":"Artesunate Vaginal Inserts/ Pessaries"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Day 5","title":"To Determine the Maximum Concentration of Dihydroartemisinin (DHA) (Cmax)","type":"SECONDARY","unitOfMeasure":"ng/mL"}